Publications by authors named "A O Sehirli"

Apical periodontitis is an inflammatory condition resulting from microbial invasion in the root canal system, causing periapical tissue destruction and bone resorption. This study investigated melatonin's effects, known for its antioxidant and anti-inflammatory properties, on experimentally induced apical periodontitis in rats. Three groups of rats were studied: control, apical periodontitis and apical periodontitis with melatonin treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's Disease (AD) is a neurodegenerative disorder that disrupts cognitive and behavioral functions, and melatonin may help in treating it by promoting the breakdown of harmful beta-amyloid deposits and enhancing Bmal1 gene expression.
  • The study investigates how FDA-approved drugs interact with the CLOCK: Bmal1 dimer and whether combining these medications with melatonin could provide better treatment outcomes for AD.
  • Results indicate that galanthamine and donepezil have similar binding energies to melatonin at the Bmal1 binding site, suggesting a promising new treatment strategy that includes melatonin and the monoclonal antibody Lecanemab, which hasn't been thoroughly examined in previous studies.
View Article and Find Full Text PDF

Aim: This study aimed to investigate the potential protective effects of N-acetyl-L-cysteine (NAC) against apical periodontitis (AP) in rats with adriamycin (ADR)-induced kidney and heart diseases.

Methodology: Fourty-eight Wistar albino rats were divided into six groups: (1) Control group, (2) ADR group (1 mg/kg/day ip for 10 days), (3) AP Group (1st mandibular molar tooth), (4) AP + ADR Group, (5) AP + NAC group (150 mg/kg/day ip), and (6) AP + ADR + NAC group. After 3 weeks, the rats were decapitated and blood and tissue samples (heart, kidney, and jaw) were collected.

View Article and Find Full Text PDF

Chronobiology, which studies biological rhythms and their impacts on health, presents a potential avenue for treating amyotrophic lateral sclerosis. Clock gene-related therapies, focusing on genes responsible for regulating biological rhythms, may hold promise in the treatment. Among these clock genes, nuclear receptor subfamily 1 Group D member 1 (NR1D1) plays a vital role in neurodegenerative diseases.

View Article and Find Full Text PDF

Background: Ischemia-reperfusion (I/R) causes organ dysfunction as a result of the increased formation of various reactive oxygen metabolites, infiltration of inflammatory cells, interstitial edema, cellular dysfunction, and tissue death.

Aim: The study aimed to investigate the cytoprotective effect of 2-mercaptoethanesulfonate (MESNA) against tissue damage in rats exposed to carotid ischemia-reperfusion.

Materials And Methods: Twenty-four male Wistar albino rats were divided into four groups (n = 6): sham, carotid I/R, I/R + MESNA (75 mg/kg), and I/R + MESNA (150 mg/kg) groups.

View Article and Find Full Text PDF